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BackgroundzzThe safety of repeated mechanical thrombectomy within the acute stroke pe-
riod has not yet been clearly demonstrated. We describe herein a patient who was successful-
ly treated with repeated mechanical thrombectomy within the acute index stroke period.
Case ReportzzA 50-year-old woman with atrial fibrillation presented with left-sided weak-
ness caused by occlusion of the right middle cerebral artery (MCA). Emergent mechanical 
thrombectomy with the Solitaire device achieved complete recanalization. The left MCA occlu-
sion redeveloped at 6 days after the first treatment, at which time her international normalized 
ratio (INR) was 2.3. Endovascular thrombectomy was reattempted rapidly and complete re-
canalization was achieved again. Her neurologic symptoms resolved after the thrombectomy.
ConclusionszzThis case demonstrates that repeated mechanical thrombectomy can be safely 
and successfully performed even in a patient with a high INR and a recurrent stroke during the 
acute period after the index stroke.
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Recurrent Cardioembolic Stroke Treated Successfully  
with Repeated Mechanical Thrombectomy  
within the Acute Index Stroke Period
INTRODUCTION
Mechanical thrombectomy has been widely used to treat hyperacute ischemic stroke in 
recent years.1 This procedure can be useful even when chemical thrombolysis is not possi-
ble because of the potential risk of hemorrhagic complications.2,3 However, the safety of 
repeated mechanical thrombectomy within the acute index stroke period has not yet 
been clearly demonstrated. We report herein a patient who was successfully treated twice 
with mechanical thrombectomy due to recurrent cardioembolic stroke within the acute 
index stroke period. Light microscopy of the thromboemboli confirmed their cardioem-
bolic origin.
CASE REPORT
A 50-year-old woman was admitted to our emergency room with left-sided weakness of 
5 hours and 45 minutes duration. She had been taking warfarin due to chronic atrial fi-
brillation for 10 years (CHA2DS2 VASc score=2). An initial neurologic examination re-
vealed dysarthria, left visual field defect, and face and limb weakness on the left side. Vi-
suospatial neglect on the left side was also noted. Electrocardiography revealed an atrial 
fibrillation. Her international normalized ratio (INR) was 1.74. Brain computed tomog-
raphy (CT) angiography revealed tandem occlusion of the right distal internal carotid ar-
Yoonju Leea  
Han Yia  
Byoung Moon Kimb  
Dong Joon Kimb  
Se Hoon Kimc  
Hyo Suk Nama  
Ji Hoe Heoa  
Young Dae Kima
aDepartments of Neurology,  
bRadiology, and  
c Pathology, Yonsei University  
College of Medicine, Seoul, Korea
pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015;11(3):275-278   /   http://dx.doi.org/10.3988/jcn.2015.11.3.275
Received September 13, 2013
Revised November 1, 2013
Accepted November 7, 2013
Correspondence
Young Dae Kim, MD, PhD
Department of Neurology, 
Yonsei University 
College of Medicine,
50-1 Yonsei-ro, Seodaemun-gu, 
Seoul 120-752, Korea
Tel    +82-2-2228-1619
Fax   +82-2-393-0705
E-mail    neuro05@yuhs.ac
cc  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com-
mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original work is properly cited.
JCN  Open Access CASE REPORT
276  J Clin Neurol 2015;11(3):275-278
Repeated Thrombectomy during Acute PeriodJCN
tery (ICA) and right proximal middle cerebral artery (MCA) 
along with low densities in the right insula and the basal gan-
glia. Emergent mechanical thrombectomy was performed 
(Fig. 1A). A 0.58 mm microcatheter was navigated across the 
occlusion site to the M2 portion of the right MCA using a 
0.36 mm microwire. After removing the microwire, a Soli-
taire (ev3 Inc., Irvine, CA, USA) 4/20 stent was introduced 
and placed spanning the entire length of the thrombus. The 
Solitaire stent was retrieved during compression of the right 
common carotid artery, 5 minutes after deployment. After 
four attempts using this procedure, recanalization of the right 
ICA and MCA was achieved with capturing of the occluding 
thrombus, but the M2 superior division remained occluded. 
Another attempt at mechanical thrombectomy of the right 
M2 was conducted and complete recanalization (thrombol-
ysis in cerebral infarction score, 3) was achieved at 8 hours 
and 15 minutes after symptom onset. A delayed angiogram 
revealed complete recanalization without residual stenosis 
(Fig. 1B). Brain magnetic resonance imaging (MRI) per-
formed on the next day revealed an acute infarction in the 
right insula and basal ganglia with patent flows in the right 
ICA and MCA (Fig. 1C). The patient had no neurologic se-
quelae on day 3 after stroke onset. She had been adminis-
tered intravenous heparin, and switching to warfarin was 
attempted. 
Transthoracic echocardiography performed 5 days after 
the stroke onset demonstrated the presence of a thrombus, 
severe spontaneous echo contrast in the left atrium with left-
atrium enlargement (volume of 142.6 mL), and decreased left 
atrial appendage (LAA) emptying velocity (0.087 m/sec). On 
day 6 after symptom onset, a 22-mm-sized thrombus with 
marked left atrial enlargement was noted in the LAA on mul-
tichannel cardiac CT (Fig. 1D). Aphasia and right-sided hemi-
plegia developed 2 hours and 45 minutes after cardiac CT was 
performed. The patient’s INR was 2.34. Brain CT angiography 
revealed a newly developed occlusion on the M1 segment of 
the left MCA. Endovascular thrombectomy was attempted 
again (Fig. 1E). Complete recanalization was achieved at 2 
hours after symptom onset with the first attempt at suction 
thrombectomy and one trial mechanical thrombectomy with 
the Solitaire (ev3 Inc.) device for left M1 occlusion (Fig. 1F). 
The patient’s neurologic symptoms again completely resolved 
immediately after successful thrombectomy. Diffusion-weight-
ed MRI conducted the next day revealed a slightly high signal 
intensity in the left basal ganglia (Fig. 1G). Follow-up multi-
channel cardiac CT performed 3 days after the second event 
confirmed the disappearance of the previously observed throm-
bus in the left atrium, but a small residual thrombus was sus-
pected in the LAA (Fig. 1H). The patient was discharged to 
home 10 days later.
Histologic studies were performed to investigate the na-
ture of the thromboemboli that had been retrieved during 
the endovascular treatments for this patient. Hematoxylin 
and eosin (H&E) staining of the extracted thromboembolus 
Fig. 1. Digital subtraction angiography (DSA), brain MRI, and coronary computed tomography (CT) of the patient. A: Initial DSA showing throm-
boembolic occlusion of the right distal internal carotid artery (ICA). B: Mechanical thrombectomy with the Solitaire (ev3 Inc.) device against the 
right distal ICA and middle cerebral artery (MCA), which achieved complete recanalization. C: Diffusion-weighted MRI revealing an acute infarc-
tion in the right insula and basal ganglia. D: Coronary CT demonstrating a 22-mm-sized thrombus (white arrow) in the left atrial appendage. E: 
The patient suffered a second stroke 6 days after the index stroke; DSA revealing embolic occlusion of the left proximal MCA. F: The left MCA was 
successfully reopened after mechanical thrombectomy using the suction thrombectomy and Solitaire (ev3 Inc.) devices. G: Follow-up diffusion-
weighted MRI revealing a slightly increased signal intensity in the left basal ganglia. H: Follow-up coronary CT after the second stroke confirming 
disappearance of the thrombus in the heart.
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of the index stroke revealed a large amount of fresh red 
blood cells (RBCs) and intact granulocytes (Fig. 2A and C), 
while the clot of the second stroke contained few intact 
RBCs and granulocyte apoptosis (Fig. 2D and F). However, 
antiglycophorin-A staining, which is used for highly selec-
tive detection of RBCs, revealed that both thrombi were 
mostly composed of RBCs (Fig. 2B and E).
DISCUSSION
Mechanical thrombectomy has several advantages over phar-
macological thrombolysis, since it not only enables a longer 
treatment window but also achieves faster recanalization 
with a higher success rate,4 and it can be considered in cases 
of recent stroke or significant abnormalities in hemostasis or 
for patients with contraindications for chemical thromboly-
sis.3 However, the rates of symptomatic intracranial hemor-
rhage and procedure-related complications are reportedly 
6.8–11.2% and 3.4–5.5%, respectively, in patients treated 
with mechanical thrombectomy.5,6 Previous studies have 
shown that neurologic complications can increase when pa-
tients with previous stroke are treated with an endovascular 
procedure.7 The case described herein received mechanical 
thrombectomy for the index stroke because of more than 4.5 
hours after symptom onset and a relatively high INR, which 
is a contraindication for intravenous thrombolysis. In the 
second stroke event, mechanical thrombectomy was recon-
sidered primarily because of the higher bleeding risk with 
thrombolytic agents due to the sustained high INR and the 
symptomatic ischemic lesion that had appeared 6 days previ-
ously. This patient ultimately fully recovered without any 
procedure-related complication. Thus, repeated mechanical 
thrombectomy can be safely and successfully performed in 
patients with a high INR and a recurrent stroke within the 
acute index stroke period.
We considered that the mechanism of both stroke events 
in the present case to be cardioembolism. Our patient had 
atrial fibrillation, which is known to be most common cause 
of cardioembolism, and there was no culprit lesion in the 
cerebral artery after successful recanalization. We con-
firmed that the thrombus originated from the heart in the 
second stroke event, since the thrombus detected on multi-
channel cardiac CT had disappeared in the follow-up cardiac 
CT. 
Our patient unexpectedly developed a recurrent cardio-
embolic stroke during hospitalization, despite her sustained 
INR of 2.34. The reported frequency of early cardioembolic 
stroke recurrence has varied between 1% and 22%.8 The risk 
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Fig. 2. Hematoxylin and eosin staining (original magnification ×40). (A) The extracted thrombus from the index stroke exhibited a large number of 
red blood cells (RBCs), whereas (D) the clot extracted from the second stroke appeared to have fewer RBCs and a larger amount of fibrin. However, 
antiglycophorin-A staining (original magnification ×40) revealed that the thrombus extracted following the first (B) and second (E) strokes were 
erythrocyte-rich thrombi. (C) Detail of panel A showing intact RBCs and granulocytes (white arrow). (F) Detail of panel D revealing degraded 
RBCs and granulocyte apoptosis (white arrowhead).
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factors for early embolic recurrence in cardioembolic infarc-
tion are alcohol abuse, hypertension with valvular heart dis-
ease and atrial fibrillation, nausea and vomiting, and previ-
ous cerebral infarct.8 Although the therapeutic intensity of 
warfarin therapy is effective at preventing embolic events, 
previous reports have suggested that a history of previous 
thromboembolic events and LAA abnormalities are predic-
tive factors for the development of cerebral embolism.9 Our 
patient had a history of cardioembolic stroke 1 week before 
and severe spontaneous echo contrast in the LAA with a de-
creased LAA emptying velocity. These features, which are 
suggestive of pronounced cardiac abnormality in atrial fi-
brillation, may be related to sustained thrombogenesis de-
spite appropriate anticoagulation.
The mechanism underlying the production of a red throm-
bus differs from that of a platelet-rich thrombus (white throm-
bus). Atrial fibrillation promotes abnormal blood flow with 
turbulence and blood stasis, which enhances procoagulant 
activity by endothelial activation. This disrupts the laminar 
flow that is necessary to prevent the wash out and dilution of 
clotting factors. The aging of a thrombus can be classified 
pathologically into the following two groups according to 
previously accepted definitions:10 1) a fresh thrombus (<1 
day) is composed of a layered pattern of platelets, fibrin, 
erythrocytes, and intact granulocytes; and 2) lytic and orga-
nized thrombi (>1 day) are characterized by areas of necro-
sis, apoptosis, and karyorrhexis of granulocytes. In particu-
lar, thrombus age can be estimated based in the presence of 
intact granulocytes (average life span of 5.4 days) as well as 
erythrocytes. The thrombus at the second stroke in our case 
seemed to be a poor RBC-rich thrombus based on H&E 
staining, but a large RBC component remained on antigly-
cophorin-A staining which is known to detect the sialogly-
coprotein of RBC membranes for up to 6 days in water and 
15 days in air.11 These findings suggest that the size of the 
RBC component in the intracardiac thrombi did not alter 
during maturation of the thrombus in the heart. Further-
more, the first thrombus was considered a fresh one be-
cause it exhibited intact RBCs and granulocytes, while the 
second thrombus exhibited RBCs with an abnormal shape 
and granulocyte apoptosis, which suggests an older throm-
bus. Although there are no data regarding direct compari-
sons between antiglycophorin-A staining and H&E staining 
in terms of thrombus age, our findings were suggestive of 
the aging process of cardiac thrombus.10,11
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